Wasting as independent risk factor for mortality in chronic heart failure

Lancet

Volumn 349, Issue 9058, 1997, Pages 1050-1053

  Anker, Stefan D ^a,b   Ponikowski, Piotr ^a   Varney, Susan ^a   Chua, Tuan Peng ^a   Clark, Andrew L ^c   Webb Peploe, Katharine M ^a   Harrington, Derek ^a   Kox, Wolfgang J ^d   Poole Wilson, Philip A ^a   Coats, Andrew J S ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c WESTERN INFIRMARY   (United Kingdom)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CACHEXIA; EXERCISE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE ATROPHY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL; WEIGHT REDUCTION;

EID: 0030972278     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)07015-8     Document Type: Article

References (24)

1. Anker SD, Coats AJS. Metabolic, functional, and haemodynamic staging for CHF? Lancet 1996; 348: 1530-31.
2. Franciosa JA, Wilen M, Ziesche S, Cohn J. Survival in men with severe heart failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983; 51: 831-36.
3. Szlachic J, Massie BM, Kramer BL, Topic N, Tubau J. Correlates and prognostic indication of exercise capacity in chronic congestive heart failure. Am J Cardiol 1985; 55: 1037-42.
4. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 83: 778-86.
5. Parameshwar J, Keegan J, Sparrow J, Sutton GC, Poole-Wilson PA. Predictors of prognosis in severe chronic heart failure. Am Heart J 1992; 123: 421-26.
6. Madsen BK, Hansen JF, Stokholm KH, Brøns J, Husum D, Motensen LS. Description of survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms. Eur Heart J 1994; 15: 303-10.
7. Roul G, Moulichon M-E, Bareiss P, et al. Prognostic factors of chronic heart failure in NYHA class II or III: value of invasive exercise haemodynamic data. Eur Heart J 1995; 16: 1387-98.
8. Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986; 73: 257-67.
9. Pacher R, Stanek B, Hülsmann M, et al. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coll Cardiol 1996; 27: 633-41.
10. Swedberg K, Eneroth P, Kjekhus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990; 82: 1730-36.
11. Francis GS, Cohn JN, Johnson G, et al. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. Circulation 1993; 87 (suppl VI): VI-40-48.
12. Omland T, Aakvaag A, Bonarjee VVS, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation 1996; 93: 1963-69.
13. Tsutamoto T, Hisanaga T, Fukai D, et al. Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure. Am J Cardiol 1995; 76; 803-08.
14. Ferrari R, Bachetti T, Confortini R, et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995; 92: 1479-86.
15. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 1996; 27: 1201-06.
16. Kotler DP, Tierney AR, Wang J, Pierson RN Jr. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989; 50: 444-47.
17. Chlebrowski RT, Grosvenor MB, Bernhard NH, Morales LS, Bulcavage LM. Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS. Am J Gastroenterol 1989; 84: 1288-93.
18. Souhami RL. Cancer: clinical features and management. In: Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford textbook of medicine, 3rd edn. Oxford: Oxford University Press, 1996: 240-42.
19. Abel RM, Fischer J, Buckley MJ, Barnett GO, Austen WG. Malnutrition in cardiac surgical patients. Arch Surg 1976; 111: 45-50.
20. Otaki M. Surgical treatment of patients with cardiac cachexia: an analysis of factors affecting operative mortality. Chest 1994; 105: 1347-51.
21. Carr JG, Stevenson LW, Walden JA, Heber D. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1989; 63: 709-13.
22. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-41.
23. Tracey KJ, Morgello S, Koplin B, et al. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production: cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. J Clin Invest 1990; 86: 2014-24.
24. Anker SD, Swan JW, Chua TP, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure: the importance for cardiac cachexia. Circulation (in press).